Live
Lonza NewsLonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma PostEli LillyGilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSNThermo FisherThe Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo FinanceBio-Gene Technology LtdBio-Gene lifts placement size with additional shares and options - TipRanks10x Genomics BlogThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - AOL.comEli LillyGilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - StocktwitsPfizerPfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord PharmaEndpoints NewsOtsuka touts new IgAN evidence as it seeks full approval for VoyxactAgilentA Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.stBoston ScientificBoston Scientific to open $138M medical device distribution facility in Indiana, adding 300 jobs - MassDeviceCharles RiverCharles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWSEndpoints NewsActing FDA chief isn't interested in permanent role
BioWorld 14. Apr. 2026

Adlai Nortye identifies new GTPase KRAS inhibitors

Adlai Nortye identifies new GTPase KRAS inhibitors

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.